Stock Quote
No news stories for this company within the last 30 days.
AEGR.OQ
More News
| Press Releases
| Key Developments
Profile
Aegerion Pharmaceuticals, Inc. (Aegerion) is a biopharmaceutical company focused on the development and commercialization of small-molecule therapeutics to treat cardiovascular and metabolic disease. The Company’s two product candidates are microsomal triglyceride transfer protein inhibitors... Full Description
Company Web Links
Company Address
Aegerion Pharmaceuticals, Inc.
CenterPointe IV
1140 Route 22 East
Suite 304
Bridgewater NJ 08807
P: +1908.7072100
F: +1908.5411155
CenterPointe IV
1140 Route 22 East
Suite 304
Bridgewater NJ 08807
P: +1908.7072100
F: +1908.5411155
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Pfizer Inc. | $18.85 | +0.68 |
| JAPAN TOBACCO INC. | ¥256,200.00 | -900.00 |
| Schering-Plough Corporation | -- | -- |
| AEGR.OQ | Industry | |
|---|---|---|
| P/E(TTM) | -- | 3.60 |
| P/S(TTM) | -- | 0.55 |
| ROI(TTM) | -- | 1.85 |
| ROE(TTM) | -- | 2.50 |
No consensus estimates data available.
| Total Revenue | $--M |
| Net Income | $--M |
| EPS | $-- |
